CRON

2.76

3.50% -0.10

Handel nachbörslich: 2.78 0.02 +0.72%

Cronos Group Inc (CRON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.86

Offen:

$2.85

24-Stunden-Volumen:

810.89K

Relative Volume:

0.55

Marktkapitalisierung:

$1.03B

Einnahmen:

$159.54M

Nettoeinkommen (Verlust:

$5.06M

KGV:

-627.27

EPS:

-0.0044

Netto-Cashflow:

$26.19M

1W Leistung:

-3.16%

1M Leistung:

+0.73%

6M Leistung:

+2.60%

1J Leistung:

+35.29%

1-Tages-Spanne:

$2.75

$2.875

1-Wochen-Bereich:

$2.75

$2.94

52-Wochen-Spanne:

$1.925

$3.43

Cronos Group Inc Stock (CRON) Company Profile

Firmenname

Cronos Group Inc

Sektor

Healthcare (1100)

Branche

Drug Manufacturers - Specialty & Generic (86)

Telefon

(416) 504-0004

Adresse

4491 CONCESSION RD 12, STAYNER, ON

Mitarbeiter

610

Twitter

@cronosgroup

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

CRON's Discussions on Twitter

Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRON Cronos Group Inc	2.76	1.04B	159.54M	5.06M	26.19M	-0.0044
TAK Takeda Pharmaceutical Co Adr	16.89	50.65B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.72	41.09B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.29	39.45B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.42	30.13B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	547.25	23.00B	3.17B	1.29B	1.01B	27.09

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-01-27	Eingeleitet	Canaccord Genuity	Buy
2022-11-02	Eingeleitet	Bernstein	Mkt Perform
2022-07-28	Hochstufung	Canaccord Genuity	Hold → Buy
2022-05-11	Hochstufung	CIBC	Neutral → Sector Outperform
2022-03-22	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-27	Hochstufung	Jefferies	Underperform → Hold
2021-11-18	Fortgesetzt	BofA Securities	Underperform
2021-04-28	Fortgesetzt	BofA Securities	Underperform
2021-02-22	Herabstufung	CIBC	Sector Outperform → Neutral
2020-06-24	Hochstufung	Raymond James	Mkt Perform → Outperform
2020-04-27	Herabstufung	Raymond James	Outperform → Mkt Perform
2020-04-14	Herabstufung	Piper Sandler	Overweight → Neutral
2020-04-02	Herabstufung	BofA/Merrill	Buy → Neutral
2020-03-31	Herabstufung	Canaccord Genuity	Hold → Sell
2020-03-04	Hochstufung	MKM Partners	Neutral → Buy
2020-03-03	Herabstufung	Stifel	Buy → Hold
2019-10-18	Hochstufung	Stifel	Hold → Buy
2019-09-20	Eingeleitet	MKM Partners	Neutral
2019-09-05	Hochstufung	BMO Capital Markets	Underperform → Market Perform
2019-08-13	Eingeleitet	Piper Jaffray	Overweight
2019-08-09	Hochstufung	Canaccord Genuity	Sell → Hold
2019-06-28	Eingeleitet	Consumer Edge Research	Equal Weight
2019-06-06	Eingeleitet	Stifel	Hold
2019-06-05	Hochstufung	BofA/Merrill	Underperform → Buy
2019-04-17	Eingeleitet	BofA/Merrill	Underperform
2019-03-27	Herabstufung	Canaccord Genuity	Hold → Sell
2019-02-25	Eingeleitet	Jefferies	Underperform
2019-01-18	Eingeleitet	CIBC	Sector Outperform

Alle ansehen

Cronos Group Inc Aktie (CRON) Neueste Nachrichten

Jul 01, 2026

Cronos Group Inc.'s Equity Buyback announced on May 8, 2025, has expired. - marketscreener.com

Jul 01, 2026

Jun 30, 2026

Cronos appoints ATB Cormark as new broker for C... - Pluang

Jun 30, 2026

Cronos Group changes broker for share repurchase program - Investing.com

Jun 30, 2026

Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada - GlobeNewswire

Jun 30, 2026

Cronos Group (CRON) adds director Darren Chester Broughton as reporting insider on Form 3 - Stock Titan

Jun 30, 2026

CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? - Yahoo Finance

Jun 24, 2026

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders - Sahm

Jun 24, 2026

Jun 23, 2026

Cronos Shareholders Approve Directors, Say-on-Pay and Auditor - The Globe and Mail

Jun 23, 2026

Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch

Jun 23, 2026